Hepatitis B Market to Reach New Heights in Growth by 2032, DelveInsight Predicts | Arbutus Biopharma, GSK/Ionis Pharma, Vir Biotech, Dong-A ST Co., Ltd., Barinthus Biotherapeutics, GC Biopharma Corp

DelveInsight's "Hepatitis B Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Hepatitis B, historical and forecasted epidemiology as well as the Hepatitis B market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Hepatitis B market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hepatitis B Market Forecast @ https://www.delveinsight.com/sample-request/hepatitis-b-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Some of the key facts of the Hepatitis B Market Report:
• In January 2025:- Janssen Research & Development LLC:- A Phase 2 Randomized, Open-label, Parallel-group, Multicenter Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Response to Combination Regimens Containing JNJ-73763989 and Nucleos(t)Ide Analog With or Without JNJ-56136379 in Patients With Chronic Hepatitis B Virus Infection
• According to estimates provided by the Hepatitis B Foundation, National Foundation for Infectious Diseases (2018), and the CDC, the total number of chronic hepatitis B cases is estimated to be approximately 2.2 million or higher.
• In 2023, the United States recorded approximately 881,700 diagnosed prevalent cases of chronic hepatitis B.
• In the European Union's four largest countries plus the United Kingdom (EU4+UK), Germany had the highest diagnosed prevalence of chronic hepatitis B, totaling approximately 175,000 cases, whereas Spain had the lowest diagnosed prevalence, with around 52,500 cases in 2023.
• Key Hepatitis B Companies: Arbutus Biopharma, GSK/Ionis Pharmaceuticals, Vir Biotechnology, Dong-A ST Co., Ltd., Barinthus Biotherapeutics, GC Biopharma Corp, Brii Biosciences Limited, Vir Biotechnology, Inc., Arbutus Biopharma Corporation, Erasmus Medical Center, Daewoong Pharmaceutical Co., Ascletis Pharmaceuticals, Gilead Sciences, Fujian Akeylink Biotechnology, Chia Tai Tianqing Pharma, Janssen Research & Development, LLC, Hoffmann-La Roche, Chengdu Suncadia Medicine, Suzhou Ribo Life Science, Arbutus Biopharma Corporation, Ascentage Pharma Group, and others
• Key Hepatitis B Therapies: AB-729, Bepirovirsen, Elebsiran, GSK3965193, DA-2803, ChAdOx1-HBV, Undiluted I.V.-Hepabig inj(GC5103), PEG-IFNα, VIR-3434, AB-729, ISA104, Vemliver tablet, ASC22, TAF, GST-HG131, TQA3605 tablets, JNJ-73763989, Nucleos(t)ide (NUC), HRS9950 tablets, RBD1016, Imdusiran, APG-1387, and others
• The Hepatitis B epidemiology based on gender analyzed that in 2023, there were more diagnosed prevalent cases of chronic hepatitis B (CHB) among males than females in the United States.
• The Hepatitis B market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hepatitis B pipeline products will significantly revolutionize the Hepatitis B market dynamics.

Hepatitis B Overview
Hepatitis B is a viral infection that primarily affects the liver, caused by the hepatitis B virus (HBV). It can lead to both acute and chronic liver disease and is one of the most common infectious diseases worldwide. Hepatitis B can be transmitted through contact with infected blood, semen, or other body fluids, as well as from mother to baby during childbirth.

Get a Free sample for the Hepatitis B Market Forecast, Size & Share Analysis Report @ https://www.delveinsight.com/sample-request/hepatitis-b-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Hepatitis B Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Hepatitis B Epidemiology Segmentation:
The Hepatitis B market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Hepatitis B
• Prevalent Cases of Hepatitis B by severity
• Gender-specific Prevalence of Hepatitis B
• Diagnosed Cases of Episodic and Chronic Hepatitis B

Download the report to understand which factors are driving Hepatitis B epidemiology trends @ Hepatitis B Epidemiology Forecast- https://www.delveinsight.com/sample-request/hepatitis-b-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Hepatitis B Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hepatitis B market or expected to get launched during the study period. The analysis covers Hepatitis B market uptake by drugs, patient uptake by therapies, and sales of each drug.

Hepatitis B Therapies and Key Companies
• AB-729: Arbutus Biopharma
• Bepirovirsen: GSK/Ionis Pharmaceuticals
• Elebsiran: Vir Biotechnology
• GSK3965193: GlaxoSmithKline
• DA-2803: Dong-A ST Co., Ltd.
• ChAdOx1-HBV: Barinthus Biotherapeutics
• Undiluted I.V.-Hepabig inj(GC5103): GC Biopharma Corp
• PEG-IFNα: Brii Biosciences Limited
• VIR-3434: Vir Biotechnology, Inc.
• AB-729: Arbutus Biopharma Corporation
• ISA104: Erasmus Medical Center
• Vemliver tablet: Daewoong Pharmaceutical Co. LTD.
• ASC22: Ascletis Pharmaceuticals
• TAF: Gilead Sciences
• GST-HG131: Fujian Akeylink Biotechnology
• TQA3605 tablets: Chia Tai Tianqing Pharma
• JNJ-73763989: Janssen Research & Development, LLC
• Nucleos(t)ide (NUC): Hoffmann-La Roche
• HRS9950 tablets: Chengdu Suncadia Medicine
• RBD1016: Suzhou Ribo Life Science
• Imdusiran: Arbutus Biopharma Corporation
• APG-1387: Ascentage Pharma Group

Discover more about therapies set to grab major Hepatitis B market share @ Hepatitis B Treatment Landscape- https://www.delveinsight.com/sample-request/hepatitis-b-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Hepatitis B Market Strengths
• The high prevalence of CHB is the primary strength of its global market, leading to more focus by pharmaceutical firms.
• New diagnostic biomarkers that help identify patients with CHB have been introduced for the diagnosis.

Hepatitis B Market Opportunities
• One of the major opportunities is the new diagnostic tools or methods that can be explored for the early detection of CHB in the affected patient's pool.
• Research work can be conducted to explore more of the conventional therapeutic (NAs) methods to reduce the side effects associated with the medications for CHB.

Scope of the Hepatitis B Market Report
• Study Period: 2019-2032
• Coverage: 7MM
• Key Hepatitis B Companies: Arbutus Biopharma, GSK/Ionis Pharmaceuticals, Vir Biotechnology, Dong-A ST Co., Ltd., Barinthus Biotherapeutics, GC Biopharma Corp, Brii Biosciences Limited, Vir Biotechnology, Inc., Arbutus Biopharma Corporation, Erasmus Medical Center, Daewoong Pharmaceutical Co., Ascletis Pharmaceuticals, Gilead Sciences, Fujian Akeylink Biotechnology, Chia Tai Tianqing Pharma, Janssen Research & Development, LLC, Hoffmann-La Roche, Chengdu Suncadia Medicine, Suzhou Ribo Life Science, Arbutus Biopharma Corporation, Ascentage Pharma Group, and others
• Key Hepatitis B Therapies: AB-729, Bepirovirsen, Elebsiran, GSK3965193, DA-2803, ChAdOx1-HBV, Undiluted I.V.-Hepabig inj(GC5103), PEG-IFNα, VIR-3434, AB-729, ISA104, Vemliver tablet, ASC22, TAF, GST-HG131, TQA3605 tablets, JNJ-73763989, Nucleos(t)ide (NUC), HRS9950 tablets, RBD1016, Imdusiran, APG-1387, and others
• Hepatitis B Therapeutic Assessment: Hepatitis B current marketed and Hepatitis B emerging therapies
• Hepatitis B Market Dynamics: Hepatitis B market drivers and Hepatitis B market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Hepatitis B Unmet Needs, KOL's views, Analyst's views, Hepatitis B Market Access and Reimbursement

To know more about Hepatitis B companies working in the treatment market, visit @ Hepatitis B Clinical Trials and Therapeutic Assessment- https://www.delveinsight.com/sample-request/hepatitis-b-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Contents
1. Hepatitis B Market Report Introduction
2. Executive Summary for Hepatitis B
3. SWOT analysis of Hepatitis B
4. Hepatitis B Patient Share (%) Overview at a Glance
5. Hepatitis B Market Overview at a Glance
6. Hepatitis B Disease Background and Overview
7. Hepatitis B Epidemiology and Patient Population
8. Country-Specific Patient Population of Hepatitis B
9. Hepatitis B Current Treatment and Medical Practices
10. Hepatitis B Unmet Needs
11. Hepatitis B Emerging Therapies
12. Hepatitis B Market Outlook
13. Country-Wise Hepatitis B Market Analysis (2020-2034)
14. Hepatitis B Market Access and Reimbursement of Therapies
15. Hepatitis B Market Drivers
16. Hepatitis B Market Barriers
17. Hepatitis B Appendix
18. Hepatitis B Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

List of Top Selling Market Research Reports in 2025

Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Phototherapies for psoriasis market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Vascular access devices market- https://www.delveinsight.com/report-store/vascular-access-device-market
NK cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Cardiac monitoring devices market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Ventral hernia market- ttps://www.delveinsight.com/report-store/hernia-repair-devices-market
Medical marijuana market- https://www.delveinsight.com/report-store/medical-marijuana-market
Total knee arthroplasty market- https://www.delveinsight.com/report-store/knee-reconstruction-devices-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Baricose vein treatment devices market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Pouchitis market- https://www.delveinsight.com/report-store/pouchitis-market
Diabetic wound market- https://www.delveinsight.com/report-store/diabetic-wounds-market
Healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Transcatheter treatment market- https://www.delveinsight.com/report-store/transcatheter-treatment-market
Indwelling catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Overactive bladder syndrome market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Chronic neuropathic pain market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
Microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.